United States· US:62856-410_c82838dc-6934-4541-8a02-bd44ee5bb82a
DAYVIGO
A medicinal product containing lemborexant, registered in United States by Eisai Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LEMBOREXANT
- Manufacturer
- Eisai Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1162856-410-30
- ndc1162856-410-90
- ndc11628564103030 TABLET, FILM COATED in 1 BOTTLE (62856-410-30)
- ndc11628564109090 TABLET, FILM COATED in 1 BOTTLE (62856-410-90)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lemborexant in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9e79a9d-cbe4-4bcc-a4b6-242a56af87f6 GET /v1/drugs/b9e79a9d-cbe4-4bcc-a4b6-242a56af87f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "LEMBOREXANT",
"productndc": "62856-410",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": "CIV",
"strength_unit": "mg/1",
"application_number": "NDA212028",
"marketing_category": "NDA"
}See everything about lemborexant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.